Versant Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.11K | Sell |
699
-1,607
| -70% | -$11.7K | ﹤0.01% | 2142 |
|
|
2025
Q1 | $21.9K | Buy |
2,306
+511
| +28% | +$4.85K | ﹤0.01% | 1297 |
|
|
2024
Q4 | $29.6K | Buy |
1,795
+1,142
| +175% | +$18.8K | 0.01% | 809 |
|
|
2024
Q3 | $9.63K | Hold |
653
| – | – | ﹤0.01% | 1068 |
|
|
2024
Q2 | $9.06K | Sell |
653
-432
| -40% | -$5.99K | ﹤0.01% | 1023 |
|
|
2024
Q1 | $17.1K | Sell |
1,085
-62
| -5% | -$975 | ﹤0.01% | 568 |
|
|
2023
Q4 | $18.6K | Buy |
1,147
+551
| +92% | +$8.92K | 0.01% | 525 |
|
|
2023
Q3 | $7.33K | Sell |
596
-460
| -44% | -$5.66K | ﹤0.01% | 835 |
|
|
2023
Q2 | $17K | Sell |
1,056
-674
| -39% | -$10.8K | 0.01% | 568 |
|
|
2023
Q1 | $30.1K | Buy |
1,730
+1,166
| +207% | +$20.3K | 0.01% | 372 |
|
|
2022
Q4 | $5.21K | Sell |
564
-187
| -25% | -$1.73K | ﹤0.01% | 880 |
|
|
2022
Q3 | $6K | Buy |
751
+120
| +19% | +$959 | ﹤0.01% | 791 |
|
|
2022
Q2 | $5K | Buy |
631
+271
| +75% | +$2.15K | ﹤0.01% | 867 |
|
|
2022
Q1 | $4K | Buy |
+360
| New | +$4K | ﹤0.01% | 963 |
|